Business Wire

3 Factors Contribute to Taiwan’s Success Against COVID-19: Former VP

13.7.2020 11:21:00 EEST | Business Wire | Press release

Share

Ever wondered how Taiwan, despite its geographical proximity to China, managed to keep the COVID-19 at bay? Well, Taiwan’s former vice president, Chen Chien-jen, has some answers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200713005239/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Then Vice President Chen Chien-jen speaks to the media at the Presidential Office Building on May 14, thanking the Taiwanese people for contributing to the success in the battle against the COVID-19, a few days before he left office. CNA photo May 14, 2020

“I think there were three important factors that contributed to this: a prudent attitude in dealing with COVID-19, prompt actions in responding to different situations, and forward planning before a crisis,” Chen said in a webcast program produced by the Talent Circulation Alliance and the American Institute in Taiwan June 24.

One example of these was Taiwan’s learning of the situation in Wuhan, where the coronavirus was first detected in late 2019, from a bulletin board system in Taiwan and immediately screening passengers arriving from that city, Chen said.

Chen, an epidemiologist, said Taiwan also began taking measures to prevent hospital infections, enhanced contact tracing, and quarantined people who had close contact with confirmed cases.

In addition, the activation of the Central Epidemic Command Center to coordinate government response, the requisition of face masks, and the pre-positioning of medical supplies all contributed to Taiwan’s success against COVID-19, Chen said.

Taiwan was able to increase its daily production capacity of surgical masks from 1.88 million to 20 million in just over a month.

The government’s detailed explanation of its coronavirus prevention measures gave the public confidence in its ability to handle the situation, resulting in people abiding by government instructions, including washing hands frequently, wearing face masks, and following home quarantine rules, he said.

Chen, who served as Taiwan's health minister during the Severe Acute Respiratory Syndrome (SARS) outbreak in 2003, also stressed the importance of talent circulation in epidemic prevention cooperation.

“No country can combat any emerging communicable disease alone,” Chen said.

During SARS, for example, Chen said Taiwan did not receive help from the WHO because of its ongoing exclusion from the U.N. special agency. Fortunately, with the assistance of 20 specialists sent by the U.S. Centers for Disease Control and Prevention, Taiwan was able to weather the health crisis, he said.

Meanwhile, the U.S. specialists brought back what they had learned from Taiwan and contributed to the setting of standard procedures in America in dealing with SARS, Chen said, “The world can be a better place if people cooperate with each other, circulate talent, and share technologies.”

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Central News Agency
Name: Jay Chen
Email: jenjey.chen@cna.com.tw
Phone: +886-2-25051180 ext. 100

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Smead Capital Management Extends International Value Strategy to Global Investors Through New Fund10.6.2026 10:00:00 EEST | Press release

Smead Capital Management, a Phoenix-based investment management firm and a leader in value investing, today announced the launch of the Smead Global ex-US Value UCITS Fund designed to provide global investors with access to a product modeled after the firm’s long-standing Smead International Value Strategy. The Smead Global ex-US Value UCITS Fund is domiciled in Luxembourg. Investors can access the fund through Smead Capital Management’s website and it is available to professional and qualified investors through the fund’s transfer agent. The strategy that the Smead Global ex-US Value UCITS Fund is modeled after, the Smead International Value Strategy, has been a core contributor to Smead Capital Management’s outstanding performance for over a decade. Like all Smead products, the Global ex-US Value UCITS Fund will be built on Smead’s eight investment criteria and a disciplined, contrarian, value approach. “Many investors around the world believe non-US companies cannot produce attracti

Dodge Opens Orders for the Next Generation Charger in Europe10.6.2026 10:00:00 EEST | Press release

An Icon Enters Its Next Generation This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609386800/en/ Celebrating its 60th anniversary this year, Dodge opens a bold new chapter in Europe with the launch of the next-generation Dodge Charger, bringing one of America’s most iconic muscle cars back to European roads through a new multi-energy lineup engineered to deliver performance and attitude without compromise. Six decades after the original Charger helped define the muscle car era, this new eighth-generation model evolves the formula for a new generation of drivers while remaining unmistakably Dodge in character, design and presence. Available with both all-electric and gasoline powertrains, the new Charger reflects Dodge’s performance-first philosophy: different powertrains, same muscle car DNA. The next-generation Charger arrives in Europe in both two-door and four-door configurations, combining iconic proportions, wide-body

Roquette Showcases Scalable Drug Delivery Innovations at CPHI China 202610.6.2026 10:00:00 EEST | Press release

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, will showcase its comprehensive portfolio of innovative drug delivery solutions at CPHI & PMEC China 2026, taking place June 16-18 at the Shanghai New International Expo Centre (SNIEC). Under the theme “One Roquette for Innovations,” Roquette’s Health & Pharma Solutions Business Unit will exhibit at booth E3D26, highlighting how its deep scientific expertise and technical capabilities enable pharmaceutical companies to turn promising formulations into scalable commercial realities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260610596225/en/ Visit Roquette at booth E3D26 to meet with its team of experts “As the pharmaceutical industry accelerates innovation, from GLP-1 therapies to complex biologics, the pressure to deliver manufacturing reliability, consistent supply, and robust formulations at scale has never been greater,” said Angela S

Trustd Brings Know Your Carrier to Market as Freight Fraud Costs European Supply Chains Over €1bn10.6.2026 09:01:00 EEST | Press release

Trustd, the digital identity and credentials verification platform for transport and logistics, is bringing to market Know Your Carrier (KYC), a web-based verification tool that lets shippers and 3PLs get an instant risk signal on carriers quoting for work via email in seconds. Cargo crime across EMEA has risen 438% in three years. More than 108,000 supply chain thefts were recorded across the region in the last two years. Of the 5% that reported a financial loss, the combined value exceeded €1bn, equivalent to €1.3m every 24 hours. Know Your Carrier draws on Trustd's expertise in digital identity verification to address a problem that has until now had no industry-wide solution. The web-based tool plugs into existing workflows with no installation or integration. Users enter an email address and, where available, a VAT number. The tool checks email legitimacy and domain matching, business registration data, adverse media, sanctions and court judgments, and Trustd’s own growing network

Sofinnova Partners Launches Collaboration with AWS to Scale AI Across Life Sciences Innovation10.6.2026 09:00:00 EEST | Press release

Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced a collaboration with Amazon Web Services (AWS), to embed AI more deeply across its investment platform and portfolio companies. The collaboration supports Sofinnova.AI, the firm’s initiative to integrate AI across its core activities, from sourcing and evaluating investments to supporting company building. At the center of this effort is Sofia, Sofinnova's proprietary AI platform, which will be extended beyond internal use to include a founder-facing version. Through this collaboration, Sofinnova-backed startups will gain access to tailored AWS resources and technical enablement, helping them move faster from early research to development and commercialization. “AI is becoming central to how new therapies are discovered, developed, and brought to patients,” said Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners. “With Sofinnova.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye